DUBLIN, Feb. 9, 2023 /PRNewswire/ — The “Global Bioinformatics Partnering Terms and Agreements 2015 to 2022” report has been added to ResearchAndMarkets.com’s offering.
This report provides details of the latest bioinformatics agreements announced in the healthcare sectors.
The report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter bioinformatics partnering deals. The majority of deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors bioinformatics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Bioinformatics is the application of computer science and information technology to the field of biology and medicine. Bioinformatics deals with algorithms, databases, information systems, web technologies, artificial intelligence, information and computation theory, software engineering, data mining, image processing, modeling, simulation, signal processing, discrete mathematics, control systems, and statistics, for generating new knowledge of biology and medicine.
Bioinformatics deals have increased in terms of popularity for partnering in the past decade, as computing power has been embraced in order to speed up the discovery, evaluation and clinical assessment processes.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of all bioinformatics partnering deals announced since January 2015, including financial terms where available, including links to online deal records of actual bioinformatics partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
In addition, a comprehensive appendix is provided organized by bioinformatics partnering company A-Z, deal type definitions and bioinformatics partnering agreements example. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report also includes numerous tables and figures that illustrate the trends and activities in bioinformatics partnering and dealmaking since 2015.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of bioinformatics technologies and products.
Global Bioinformatics Partnering Terms and Agreements provides the reader with the following key benefits:
- In-depth understanding of bioinformatics deal trends since 2015
- Access to headline, upfront, milestone and royalty data
- Detailed access to actual bioinformatics contracts enter into by the leading big-pharma companies
- Insight into the terms included in a bioinformatics agreement, together with real world clause examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Key Topics Covered:
Chapter 1 – Introduction
Chapter 2 – Trends in bioinformatics dealmaking
2.2. Bioinformatics partnering over the years
2.3. Most active bioinformatics dealmakers
2.4. Bioinformatics partnering by deal type
2.5. Bioinformatics partnering by therapy area
2.6. Deal terms for bioinformatics partnering
2.6.1 Bioinformatics partnering headline values
2.6.2 Bioinformatics deal upfront payments
2.6.3 Bioinformatics deal milestone payments
2.6.4 Bioinformatics royalty rates
Chapter 3 – Leading bioinformatics deals
3.2. Top bioinformatics deals by value
Chapter 4 – Most active bioinformatics dealmakers
4.2. Most active bioinformatics dealmakers
4.3. Most active bioinformatics partnering company profiles
Chapter 5 – Bioinformatics contracts dealmaking directory
5.2. Bioinformatics contracts dealmaking directory
Chapter 6 – Bioinformatics dealmaking by technology type
Appendix 1 – Bioinformatics deals by company A-Z
Appendix 2 – Bioinformatics deals by stage of development
Appendix 3 – Bioinformatics deals by deal type
Appendix 4 – Bioinformatics deals by therapy area
Appendix 5 – Appendix 6 – Table of figures
For more information about this report visit https://www.researchandmarkets.com/r/1ks3lx
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets